Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

6(100.0%)

6Total

N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT06179758Not ApplicableActive Not Recruiting

Remote MS Care in Antwerp

Role: collaborator

NCT06175208Not ApplicableEnrolling By Invitation

Targeting Fear of Cancer Recurrence in Cancer Survivors: Evaluation of Internet-Based Emotional Freedom Techniques and Internet-Based Mindfulness Meditation as Intervention Strategies

Role: collaborator

NCT02771028Not ApplicableCompleted

Emotional Freedom Techniques to Reduce Patient Reported Cognitive Complaints in Cancer Survivors

Role: collaborator

NCT03219086Not ApplicableCompleted

Spinal Prilocaine for Caesarian Sections

Role: collaborator

NCT04158063Not ApplicableCompleted

Cognitive-motor Interference in Persons With MS

Role: collaborator

NCT02493166Not ApplicableCompleted

Dual Task Cost in the Upper Limb in Persons With Multiple Sclerosis

Role: collaborator

All 6 trials loaded